Market Cap 17.52M
Revenue (ttm) 48,321.00
Net Income (ttm) -1.56M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -3,229.52%
Debt to Equity Ratio 0.00
Volume 142,000
Avg Vol 1,832,038
Day's Range N/A - N/A
Shares Out 21.00M
Stochastic %K 11%
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

Cuprina Holdings (Cayman) Limited, a biomedical and biotechnology company, focuses on the development and commercialization of products for the management of chronic wounds. The company manufactures and distributes a line of medical grade sterile blowfly larvae bio-dressing products used as a biological debridement tool for chronic wounds under the MEDIFLY brand name. It is also developing collagen dressings, including sponges, particles, and hydrogels using bullfrog collagen derived from the va...

Industry: Medical Instruments & Supplies
Sector: Healthcare
Phone: 65 8512 7275
Address:
Blk 1090, Lower Delta Road #06-08, Singapore, Singapore
Aguilar97
Aguilar97 Nov. 11 at 3:50 PM
$CUPR is anyone considering selling this or whose holding hopefully the approval from sfda comes soon
0 · Reply
Aguilar97
Aguilar97 Nov. 11 at 4:15 AM
$CUPR well after hours just hit 70 cents so know it doesn’t mean much but in this shit stock it clearly lays out the price point for tommorow great job David
0 · Reply
LudwigVanBeethoven
LudwigVanBeethoven Nov. 10 at 10:41 PM
$CUPR 60c holding again? day 18 < 1. about to reach max fear w/o real volume, which is more than weird :)
1 · Reply
M3li
M3li Nov. 10 at 6:12 PM
$CUPR this is getting worse
0 · Reply
Aguilar97
Aguilar97 Nov. 10 at 5:29 PM
$CUPR this is brutal this ceo needs to be more consistent with news
0 · Reply
Aguilar97
Aguilar97 Nov. 10 at 2:32 PM
$CUPR that spread to a dollar looked promising now back to 80 cents smh
0 · Reply
Heidne
Heidne Nov. 8 at 9:43 AM
$CUPR This was new fore me: Cuprina MENA Co. Ltd, a 49%-owned associate of Cuprina Holdings (Cayman) Ltd, has completed the establishment of a laboratory in Saudi Arabia designed to manufacture MEDIFLY maggot debridement therapy for chronic wound treatment. This new facility will supply the therapy throughout the Middle East and North Africa region. Additionally, Cuprina MENA has acquired exclusive rights to market medicinal leeches in the Gulf Cooperation Council countries, a treatment increasingly used for medical conditions such as venous congestion and to enhance tissue healing post-surgery. These strategic advancements are expected to broaden Cuprina's market presence in the MENA and GCC regions.
1 · Reply
Heidne
Heidne Nov. 8 at 7:51 AM
$CUPR From CEO: Hi Peter, Thank you for reaching out and for your continued support of Cuprina. I completely understand the concern regarding the recent share price and lower trading volume. Unfortunately, I can’t comment much on market movements, as they’re often influenced by factors outside of the company’s control. That said, please don’t be too worried, we remain focused on executing our strategy and strengthening the fundamentals of the business. Progress continues steadily behind the scenes, and all we can do is stay committed to our plan and trust that the results will speak for themselves in time. Regarding Dr. Sherman’s comment, yes, Cuprina is currently the second largest company in the global medical maggot therapy space. The largest is BioMonde, which operates mainly in Europe. Thank you again for your patience and faith in what we’re building, it truly means a lot to the team.
1 · Reply
LudwigVanBeethoven
LudwigVanBeethoven Nov. 7 at 8:06 PM
$CUPR day 17
1 · Reply
Aguilar97
Aguilar97 Nov. 7 at 4:25 PM
$CUPR 83 cents every day it dips lower and lower wtf
0 · Reply
Latest News on CUPR
Cuprina Holdings IPO Registration Document (F-1)

Mar 7, 2024, 4:09 PM EST - 1 year ago

Cuprina Holdings IPO Registration Document (F-1)


Aguilar97
Aguilar97 Nov. 11 at 3:50 PM
$CUPR is anyone considering selling this or whose holding hopefully the approval from sfda comes soon
0 · Reply
Aguilar97
Aguilar97 Nov. 11 at 4:15 AM
$CUPR well after hours just hit 70 cents so know it doesn’t mean much but in this shit stock it clearly lays out the price point for tommorow great job David
0 · Reply
LudwigVanBeethoven
LudwigVanBeethoven Nov. 10 at 10:41 PM
$CUPR 60c holding again? day 18 < 1. about to reach max fear w/o real volume, which is more than weird :)
1 · Reply
M3li
M3li Nov. 10 at 6:12 PM
$CUPR this is getting worse
0 · Reply
Aguilar97
Aguilar97 Nov. 10 at 5:29 PM
$CUPR this is brutal this ceo needs to be more consistent with news
0 · Reply
Aguilar97
Aguilar97 Nov. 10 at 2:32 PM
$CUPR that spread to a dollar looked promising now back to 80 cents smh
0 · Reply
Heidne
Heidne Nov. 8 at 9:43 AM
$CUPR This was new fore me: Cuprina MENA Co. Ltd, a 49%-owned associate of Cuprina Holdings (Cayman) Ltd, has completed the establishment of a laboratory in Saudi Arabia designed to manufacture MEDIFLY maggot debridement therapy for chronic wound treatment. This new facility will supply the therapy throughout the Middle East and North Africa region. Additionally, Cuprina MENA has acquired exclusive rights to market medicinal leeches in the Gulf Cooperation Council countries, a treatment increasingly used for medical conditions such as venous congestion and to enhance tissue healing post-surgery. These strategic advancements are expected to broaden Cuprina's market presence in the MENA and GCC regions.
1 · Reply
Heidne
Heidne Nov. 8 at 7:51 AM
$CUPR From CEO: Hi Peter, Thank you for reaching out and for your continued support of Cuprina. I completely understand the concern regarding the recent share price and lower trading volume. Unfortunately, I can’t comment much on market movements, as they’re often influenced by factors outside of the company’s control. That said, please don’t be too worried, we remain focused on executing our strategy and strengthening the fundamentals of the business. Progress continues steadily behind the scenes, and all we can do is stay committed to our plan and trust that the results will speak for themselves in time. Regarding Dr. Sherman’s comment, yes, Cuprina is currently the second largest company in the global medical maggot therapy space. The largest is BioMonde, which operates mainly in Europe. Thank you again for your patience and faith in what we’re building, it truly means a lot to the team.
1 · Reply
LudwigVanBeethoven
LudwigVanBeethoven Nov. 7 at 8:06 PM
$CUPR day 17
1 · Reply
Aguilar97
Aguilar97 Nov. 7 at 4:25 PM
$CUPR 83 cents every day it dips lower and lower wtf
0 · Reply
LudwigVanBeethoven
LudwigVanBeethoven Nov. 7 at 2:08 AM
$CUPR probably needs to have one of those penny funds activating their HF trading algo to simulate higher volume, stabilize price and then move it up. So some sort of an offering maybe to incentivize such weird action?
0 · Reply
LudwigVanBeethoven
LudwigVanBeethoven Nov. 7 at 2:06 AM
$CUPR will they post earnings? I guess that is required to see what they are + a CC (again) but w/ numbers/projection/guidance. Zero volume down .. nobody wants to deal with it for now still. And now .. days <1 adding up :|
0 · Reply
AlienTrador
AlienTrador Nov. 6 at 11:53 PM
$CUPR its everything
0 · Reply
Heidne
Heidne Nov. 6 at 7:03 PM
$CUPR Im buying.
0 · Reply
Apricot_Apricots
Apricot_Apricots Nov. 6 at 5:21 PM
$CUPR my guess is no action until the broader market stabilizes
1 · Reply
Heidne
Heidne Nov. 6 at 5:20 PM
$CUPR nice pics. https://www.cuprinamena.com/maggot-therapy
1 · Reply
davidwolf0
davidwolf0 Nov. 6 at 4:13 PM
$CUPR Just give us some damn news and maybe this will reverse.
0 · Reply
Aguilar97
Aguilar97 Nov. 6 at 3:01 PM
$CUPR I think we can all agree this is junk maybe years from now it won’t be
0 · Reply
Aguilar97
Aguilar97 Nov. 6 at 2:31 PM
$CUPR it gives us a shit spike then drops Below what it previously was lol
0 · Reply
AlienTrador
AlienTrador Nov. 5 at 10:45 PM
$CUPR is this fish dead in the water?
1 · Reply
Aguilar97
Aguilar97 Nov. 4 at 1:36 PM
$CUPR 90 cents
1 · Reply
ClarkSuperKent_
ClarkSuperKent_ Nov. 1 at 7:07 PM
0 · Reply